The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
1541 RISEK IV 40 OMEPRAZOLE 40MG POWDER FOR INJECTION VIAL TREATMENT OF GASTRO-ESOPHAGEAL REFLUX DISEASE, GASTRIC AND DUODENAL ULCER, TREATMENT AND PROPHYLAXIS OF NSAID-ASSOCIATED ULCERATION, ERADICATION OF H.PYLORI INFECTION ASSOCIATED WITH PEPTIC ULCER DISEASE, ZOLLINGER-ELLISON SYNDROME, DYSPEPSIA, PROPHYLAXIS OF ACID ASPIRATION. NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 08 I 2961/07 10-Feb-2023 09-Feb-2026 View
1542 ROVISTA TABLETS 10 MG ROSUVASTATIN CALCIUM 10MG FILM COATED TABLET ALU-ALU IS INDICATED: AS AN ADJUNCT TO DIET TO REDUCE ELEVATED TOTAL-C, LDL-C, NON HDL-C, APOB, AND TRIGLYCERIDES LEVELS AND TO INCREAS HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA… NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 06 I 3114/08 10-Feb-2023 09-Feb-2026 View
1543 ROVISTA TABLETS 20 MG ROSUVASTATIN CALCIUM 20MG FILM COATED TABLET ALU-ALU IS INDICATED: AS AN ADJUCT TO DIET TO REDUCE ELEVATED TOTAL-C, LDL-C, NON HDL-C, APOB, AND TRIGLYCERIDES LEVELS AND TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA… NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 06 I 3111/08 10-Feb-2023 09-Feb-2026 View
1544 ROVISTA TABLETS 5 MG ROSUVASTATIN CALCIUM 5 MG FILM COATED TABLET ALU-ALU IS INDICATED: AS AN ADJUNCT TO DIET REDUCE ELEVATED TOTAL-C, LDL-C, NON HDL-C, APOB, AND TRIGLYCERIDES LEVELS AND TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA… NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 06 I 3112/08 10-Feb-2023 09-Feb-2026 View
1545 SAN SAN SYRUP ALBENDAZOLE 200 MG / 5 ML ORAL SUSPENSION BOTTLE USED IN THE TREATMENT OF SINGLE AND MIXED INTESTINAL NEMATODE INFECTION INCLUDING ASCARIASIS, ENTEROBIASIS, HOOKWORM, STRONGYLOIDIASIS AND TRICHURIASIS. NULL LAO INTER PHARMA CO.,LTD T MAN PHARMA COMPANY LIMITED THAILAND CERTIFICATE RELEASED 01 I 5171/22 21-MAY-2025 20-MAY-2030 View
1546 SOLIFEN TABLETS 10 MG SOLIFENACIN SUCCINATE 10 MG EQ.TO SOLIFENACIN 7.5 MG FILM COATED TABLET BLISTERPACK SOLIFEN IS INDICATED FOR THE TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY AND URINARY FREQUENT MICTURITION NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 11 I 4116/15 10-Feb-2023 09-Feb-2026 View
1547 SOLIFEN TABLETS 5 MG SOLIFENACIN SUCCINATE 5 MG EQ.TO SOLIFENACIN 3.8 MG FILM COATED TABLET ALU-ALU BLISTER SOLIFEN IS INDICATED FOR THE TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY AND URINARY FREQUENCY OR FREQUENT MICTURATION. NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 03 I 4030/15 10-FEB-2025 09-FEB-2030 View
1548 T.MAN COUGH SYRUP EACH 5 ML CONTAINS: DEXTROMETHORPHAN HBR EQ.TO ANHYDROUS DEXTROMETHORPHAN HBR 10 MG, CHLORPHENIRAMINE MALEATE 2 MG, GLYCERYL GUAIACOLATE 50 MG SYRUP BOTTLE FOR RELIEF OF COMMON COLD WITH RUNNING NOSE, EXPECTORANT AND COUGH NULL LAO INTER PHARMA CO.,LTD T MAN PHARMA COMPANY LIMITED THAILAND CERTIFICATE RELEASED 07 I 5245/22 17-Aug-2022 16-Aug-2025 View
1549 T.V.GIN(MA) FILM COATED TABLET MEFENAMIC ACID 500 MG FILM COATED TABLET BOTTLE USED IN MILD TO MODERATE PAIN INCLUDING HEADACHE, DENTAL PAIN, POST OPERATIVE AND POST PARTUM PAIN AND DYSMENORRHEA, IN MUSCOLOSKELETAL AND JOINT DISORDERS SUCH AS OSTEOARTHRITIS AND REUMATOID ARTHRITIS AND IN MENORRHAGIA NULL LAO INTER PHARMA CO.,LTD T MAN PHARMA COMPANY LIMITED THAILAND CERTIFICATE RELEASED 07 I 5246/22 17-Aug-2022 16-Aug-2025 View
1550 TENOXMAN TENOXICAM 20 MG TABLET BOTTLE SYMPTOMATIC TREATMENT IN RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, ANKYLOSING SPONDYLITIS, EXTRA-ARTICULAR INFLAMMATION, ACUTE GOUT NULL LAO INTER PHARMA CO.,LTD T.MAN PHARMA CO., LTD THAILAND CERTIFICATE RELEASED 04 I 4670/19 10-FEB-2025 09-FEB-2030 View